Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA approves Paradromics' brain-computer interface trial to restore speech in severely impaired patients.
Paradromics has received FDA approval for a long-term clinical trial of its brain-computer interface, the Connexus, to restore speech in people with severe motor impairments.
The implant, a dime-sized device with 421 microwire electrodes, records neural activity from the motor cortex to translate imagined speech into text or synthetic voice output using the user’s own voice.
The trial, starting early next year, will initially involve two participants and assess safety, communication speed, and the ability to control a computer cursor.
The system has shown high data transmission rates in animal tests, potentially offering faster communication than other BCIs.
If successful, the trial may expand to up to ten participants with dual implants.
La FDA aprueba el ensayo de interfaz cerebro-computadora de Paradromics para restaurar el habla en pacientes gravemente afectados.